STE Stock Recent News
STE LATEST HEADLINES
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
STERIS' (STE) fiscal 2024 third-quarter results demonstrate the remarkable performance of the Healthcare segment.
The headline numbers for Steris (STE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Steris (STE) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.17 per share. This compares to earnings of $2.02 per share a year ago.
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
DUBLIN, IRELAND, Jan. 23, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
Investors continue to remain optimistic about STERIS (STE) due to the prospects of the healthcare business.
STERIS' (STE) Healthcare segment continues to benefit from procedure volume recovery.
STERIS plc (NYSE:STE ) Q2 2024 Earnings Conference Call November 8, 2023 9:00 AM ET Company Participants Julie Winter - Vice President of Investor Relations Dan Carestio - President and CEO Mike Tokich - Senior Vice President and CFO Conference Call Participants Jacob Johnson - Stephens, Inc. David Turkaly - JMP Securities Michael Polark - Wolfe Research Michael Matson - Needham & Company Jason Bednar - Piper Sandler Operator Good morning, everyone and welcome to the STERIS plc Fiscal Second Quarter 2024 Conference Call. All participants will be in a listen-only mode.